Combined treatment of intraoperative cell-salvage and tranexamic acid for primary unilateral total hip arthroplasty: Are there added benefits?

Miller, Thea M; Fang, Christopher; Hagar, Andrew; Anderson, Marie; Gad, Bishoy; Talmo, Carl T

Miller, Thea M; Fang, Christopher; Hagar, Andrew; Anderson, Marie; Gad, Bishoy; Talmo, Carl T.

Afiliação

Miller TM; Department of Research, New England Baptist Hospital, Boston, MA, USA.
Fang C; Department of Orthopedic Surgery, New England Baptist Hospital, Boston, MA, USA. Electronic address: cfang@nebh.org.
Hagar A; Department of Orthopedic Surgery, New England Baptist Hospital, Boston, MA, USA.
Anderson M; Department of Research, New England Baptist Hospital, Boston, MA, USA.
Gad B; Department of Orthopedic Surgery, New England Baptist Hospital, Boston, MA, USA.
Talmo CT; Department of Orthopedic Surgery, New England Baptist Hospital, Boston, MA, USA.

J Orthop Sci ; 27(1): 158-162, 2022 Jan.

Article em En | MEDLINE | ID: mdl-33341356

Assuntos

Antifibrinolíticos; Artroplastia de Quadril; Ácido Tranexâmico; Perda Sanguínea Cirúrgica/prevenção & controle; Transfusão de Sangue; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ácido Tranexâmico / Artroplastia de Quadril / Antifibrinolíticos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Orthop Sci Assunto da revista: ORTOPEDIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google